Paracetamol, its metabolites, and their transfer between maternal circulation and fetal brain in mono- and combination therapies
Open Access
- 24 January 2025
- journal article
- research article
- Published by Springer Nature in Pharmacological Reports
- Vol. 77 (2) , 474-489
Abstract
Background: Due to its availability and perceived safety, paracetamol is recommended even during pregnancy and for neonates. It is used frequently alone or in combination with other drugs required for the treatment of various chronic conditions. The aim of this study was to investigate potential effects of drug interactions on paracetamol metabolism and its placental transfer and entry into the developing brain. Methods: Sprague Dawley rats at postnatal day P4, pregnant embryonic day E19 dams, and non-pregnant adult females were administered paracetamol (15 mg/kg) either as monotherapy or in combination with one of seven other drugs: cimetidine, digoxin, fluvoxamine, lamotrigine, lithium, olanzapine, valproate. Concentrations of parent paracetamol and its metabolites (paracetamol-glucuronide, paracetamol-glutathione, and paracetamol-sulfate) in plasma, cerebrospinal fluid (CSF) and brain were measured by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and their entry into the brain, CSF and transfer across the placenta were estimated. Results: In monotherapy, concentration of parent paracetamol in plasma, CSF, and brain remained similar and at all ages brain entry was unrestricted. In combination therapies, CSF entry of paracetamol increased following co-treatment with olanzapine. Placental transfer of parent paracetamol remained unchanged, however, transfer of paracetamol-sulfate increased with lamotrigine co-administration. Acutely administered paracetamol was more extensively metabolized in adults compared to younger ages resulting in increased concentration of its metabolites with age. Conclusions: Developmental changes in the apparent brain and CSF entry of paracetamol appear to be determined more by its metabolism, rather than by cellular control of its transfer across brain and placental barriers.Keywords
All Related Versions
Funding Information
- Monash University
This publication has 53 references indexed in Scilit:
- Entry of cannabidiol into the fetal, postnatal and adult rat brainCell and tissue research, 2024
- Liquid chromatography coupled with tandem mass spectrometry for simultaneous quantification of valproate, valproate‐glucuronide and lamotrigine in various biological matrices of ratBiomedical Chromatography, 2023
- Association of Prenatal Acetaminophen Exposure Measured in Meconium With Risk of Attention-Deficit/Hyperactivity Disorder Mediated by Frontoparietal Network Brain ConnectivityJAMA Pediatrics, 2020
- Acetaminophen Use During Pregnancy, Behavioral Problems, and Hyperkinetic DisordersJAMA Pediatrics, 2014
- Application of quantitative structure–activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approachJournal of Applied Toxicology, 2009
- The blood–CSF barrier explained: when development is not immaturityBioEssays, 2008
- Effect of study protocol on the interactions between cimetidine and paracetamol in manEuropean Journal of Drug Metabolism and Pharmacokinetics, 1999
- Ontogenetic Development of Brain Barrier Mechanisms1992
- Cimetidine—Acetaminophen Interaction in HumansThe Journal of Clinical Pharmacology, 1985
- Development and regulation of bile salt sulfotransferase in rat liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982